265 related articles for article (PubMed ID: 16091196)
21. De Novo Unclassifiable CD20-Negative Diffuse Large B-Cell Lymphoma: A Diagnostic and Therapeutic Challenge.
AbdullGaffar B; Seliem RM
Int J Surg Pathol; 2018 May; 26(3):266-270. PubMed ID: 28982264
[TBL] [Abstract][Full Text] [Related]
22. FLI-1 is expressed in a wide variety of hematolymphoid neoplasms: a special concern in the differential diagnosis.
Cho U; Cha HJ; Kim HJ; Min SK; Kim HK; Jung HR; Park G; Kim JE
Clin Exp Med; 2024 Jan; 24(1):18. PubMed ID: 38280044
[TBL] [Abstract][Full Text] [Related]
23. Lineage determination of CD20- B-Cell neoplasms: an immunohistochemical study.
Chu PG; Loera S; Huang Q; Weiss LM
Am J Clin Pathol; 2006 Oct; 126(4):534-44. PubMed ID: 16938666
[TBL] [Abstract][Full Text] [Related]
24. Plasmablastic lymphoma of the retroperitoneum in an HIV- and HCV-positive patient: hard to diagnose and harder to treat.
Dholaria B; Alapat D; Pandey T; Agarwal A
Med Oncol; 2012 Dec; 29(5):3529-34. PubMed ID: 22562157
[TBL] [Abstract][Full Text] [Related]
25. CD117 expression in diffuse large B-cell lymphomas: fact or fiction?
Vakiani E; Cattoretti G; Colovai AI; Murty VV; Alobeid B; Bhagat G
Pathol Int; 2005 Nov; 55(11):716-23. PubMed ID: 16271084
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T-cell lymphomas: a phenomenon with distinctive clinicopathologic features.
Balagué O; Martínez A; Colomo L; Roselló E; Garcia A; Martínez-Bernal M; Palacín A; Fu K; Weisenburger D; Colomer D; Burke JS; Warnke RA; Campo E
Am J Surg Pathol; 2007 Sep; 31(9):1310-22. PubMed ID: 17721185
[TBL] [Abstract][Full Text] [Related]
27. Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues.
Grimm KE; O'Malley DP
Ann Diagn Pathol; 2019 Feb; 38():6-10. PubMed ID: 30380402
[TBL] [Abstract][Full Text] [Related]
28. Plasmablastic Lymphoma: A Review of Clinicopathologic Features and Differential Diagnosis.
Harmon CM; Smith LB
Arch Pathol Lab Med; 2016 Oct; 140(10):1074-8. PubMed ID: 27684979
[TBL] [Abstract][Full Text] [Related]
29. Lymphoid Neoplasms With Plasmablastic Differentiation: A Comprehensive Review and Diagnostic Approaches.
Chen BJ; Chuang SS
Adv Anat Pathol; 2020 Mar; 27(2):61-74. PubMed ID: 31725418
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr Virus-Positive CD20- and CD45-Negative Diffuse Large B-Cell Lymphoma: A Diagnostic Challenge.
Starr A; Kwon DH; Kallakury B
Int J Surg Pathol; 2019 Feb; 27(1):98-101. PubMed ID: 29968492
[TBL] [Abstract][Full Text] [Related]
31. Lymphomas occurring specifically in HIV-infected patients: from pathogenesis to pathology.
Gloghini A; Dolcetti R; Carbone A
Semin Cancer Biol; 2013 Dec; 23(6):457-67. PubMed ID: 23999127
[TBL] [Abstract][Full Text] [Related]
32. Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome.
Simonitsch-Klupp I; Hauser I; Ott G; Drach J; Ackermann J; Kaufmann J; Weltermann A; Greinix HT; Skrabs C; Dittrich C; Lutz D; Pötter R; Mannhalter C; Lechner K; Chott A; Jaeger U
Leukemia; 2004 Jan; 18(1):146-55. PubMed ID: 14603341
[TBL] [Abstract][Full Text] [Related]
33. High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma.
Deloose ST; Smit LA; Pals FT; Kersten MJ; van Noesel CJ; Pals ST
Leukemia; 2005 May; 19(5):851-5. PubMed ID: 15744337
[TBL] [Abstract][Full Text] [Related]
34. Cavity-based lymphomas: challenges and novel concepts. A report of the 2022 EA4HP/SH lymphoma workshop.
Di Napoli A; Soma L; Quintanilla-Martinez L; de Leval L; Leoncini L; Zamò A; Ng SB; Ondrejka SL; Climent F; Wotherspoon A; Dirnhofer S
Virchows Arch; 2023 Sep; 483(3):299-316. PubMed ID: 37555981
[TBL] [Abstract][Full Text] [Related]
35. Plasmablastic lymphoma and related disorders.
Hsi ED; Lorsbach RB; Fend F; Dogan A
Am J Clin Pathol; 2011 Aug; 136(2):183-94. PubMed ID: 21757592
[TBL] [Abstract][Full Text] [Related]
36. Plasmablastic transformation of low-grade B-cell lymphomas: report on 6 cases.
Martinez D; Valera A; Perez NS; Sua Villegas LF; Gonzalez-Farre B; Sole C; Gine E; Lopez-Guillermo A; Roue G; Martinez S; Sant F; Warzocha K; Robak T; Czader M; Villamor N; Colomo L; Campo E; Martinez A
Am J Surg Pathol; 2013 Feb; 37(2):272-81. PubMed ID: 23282972
[TBL] [Abstract][Full Text] [Related]
37. Morphological spectrum of AIDS-related plasmablastic lymphomas.
Gujral S; Shet TM; Kane SV
Indian J Pathol Microbiol; 2008; 51(1):121-4. PubMed ID: 18417882
[TBL] [Abstract][Full Text] [Related]
38. HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms: 2015 SH/EAHP Workshop Report-Part 3.
Chadburn A; Said J; Gratzinger D; Chan JK; de Jong D; Jaffe ES; Natkunam Y; Goodlad JR
Am J Clin Pathol; 2017 Feb; 147(2):171-187. PubMed ID: 28395104
[TBL] [Abstract][Full Text] [Related]
39. Plasmablastic lymphoma: current perspectives.
Lopez A; Abrisqueta P
Blood Lymphat Cancer; 2018; 8():63-70. PubMed ID: 31360094
[TBL] [Abstract][Full Text] [Related]
40. HIV-associated lymphomas and gamma-herpesviruses.
Carbone A; Cesarman E; Spina M; Gloghini A; Schulz TF
Blood; 2009 Feb; 113(6):1213-24. PubMed ID: 18955561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
